Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Vivani Medical

Tracked across 2 events · 13 articles · First seen Jun 25, 2026 · Last active Jun 26, 2026

Sentiment
40
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Tech
Impact: Vivani Medical received regulatory approval to initiate its SLIM-1 Phase 1 clinical trial for NPM-139, a semaglutide implant, which is a significant step in its product development and could positively impact its market position.
Jun 25, 2026 · 7 articles
2 10
Business
Impact: Vivani Medical announced the appointment of August Moretti to its board of directors and the retirement of Dr. Daniel Baker. This change is expected to bring new expertise to the company as it advances its clinical-stage drug implants.
Jun 26, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Vivani Medical live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.